The role of infectious stimulus in the initiation and immune inflammation in psoriasis

Bibliography:
1. Kubanova AA, Katunina OP. Immunomorphology and morphogenesis of affected skin foci at psoriasis. Vestn Dermatol Venerol 2010; (1): 70-79
2. Wolf R, Orion Е, Ruocco Е, Ruocco V. Abnormal epidermal barier in the pathogenesis of psoriasis. Clinics in Dermatology 2012; (30): 323-328
3. Kaganova NL, Frigo NV, Kubanov AA, Znamenskaya LE. Genetic aspects of psoriasis (A reviev of literature). Vestn Dermatol Venerol 2009; (4): 20-76
4. Novelli L, Chimenti MS, Chiricozzi A, Perricone R The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies. Autoimmunity Reviews. Jornal homehomepage:www.elsevier.com/locate/autrev/2014; (13): 1-69
5. Fry L, Baker BS. Triggering psoriasis: the role of infections and medications. Clin Dermatol 2007; (25): 606-615
6. Katunina OP, Rezaikina AV Current concepts of skin involvement in immune processes. Vestn Dermatol Venerol 2009; (2): 39-36
7. Tjurin JA, Mustafin IG, Fassahov RC. Prirodnaia ustoycivost bacterie factorsimmune systems, obuslovlennaia proteasami bacteria. Practiche Medicine. Kasan, 2010; 1: 7-13
8. Mansson A, Adrier М, Cardell LQ. Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis. Respir Res 2006; (7): 36-7
9. Ryan C, Korman NJ, Gelfand JM, et al. Research gaps in psoriasis: opportunities for future studies. J Acad Dermatol. 2014; 70(1): 1-20
10. Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N EnglJ Med 2002; (347): 1151-1160
11. Clarke LE, Helni KF, Hennessy J, Clark JT. Dermal dendritic ctll in psoriasis, dermatitis and normal-appearting skin. J Am Acad Dermatol Volume, 2011; 64 (3): 464-472
12. Macias E, Pereira F, Rietkerk W, Safai B. Superantigens in dermatology. J Am Acad Dermatology 2011; (4): 455-472
13. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med 2009; (5): 496-509
14. Zenz R, Eferi R, Kenner L, et al. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 2005; (437): 369-375
15. Sano S, Chan KS, Carbajal S, et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 2005; (11): 43-49
16. Williams ML, Elias PM. From basket weave to barrier. Unifying conctpts for the disorders of cornificftion. Arch Dermatol 1993; (129): 626-629
17. Jablonska S. Pathogenesis and treatment psoriasis. 1981
18. Prinz JO Psoriasis vulgaris — a sterile antibacterial skin reaction mediated by cross-reactive T cells? An immunological view of the pathophysiology of psoriasis. Review Clin Exp Dermatol 2001; (6): 326-332
19. Prinz JO Disease mimicry — a phatogenetic conce for T-cell-mediated autoimmune disorders triggered by molecular mimicry? Autoimmun Rev 2004; (3): 10-15
20. Weisenseel P, Prinz JO Incidental detection os S.pyogenes-DNA in psoriatic skin by PCR. Arch Dermatol Res 2005; (296): 573-576
21. Baker BS, Laman JD, PowlesA, et al. Peptidoglycan and Peptidoglycan-specific Th-1 cells in psoriasis lesions. J Pathol 2006; 209: 174-181
22. Elewski B. Does Piturosporum ovale have a role in psoriasis? Arch Dermatol 1990; (126): 1111-1112
23. Waldman A, GilharA, Duck L, et al. Incidence of Candida in psoriasua — a study on the fungal flora о psoriatic patients. Mycoses 1990; 33: 29-32
24. Moles JP, Hadi JC, Guilhou JJ. High prevalenseof an IgG response against murine leukaemia virus (MLV) in patients with psoriasis. Virus Res 2003; (94): 97-101
25. Reich A. Batycka-Baran. New Insights into the Pathogenesis of Psoriasis. European Dermatology 2010; (5: R): 10-15
26. McFadden J, Fry L, Powles AV, Kimber I. Concepts in psoriasis: psoriasis and the extracellular matrix. Brit J Dermatology 2012; (167): 980-986
27. McMilln DL, Richards DG, Mein EA, Nelson CD. Systemic Aspects of Psoriasis: An Integrative Model Based on Intestinal Etiology. Int Med. 1999; (2/3): 105-113
28. Owen CM, Chalmers RJ, O'Sullivan T, Griffiths СЕ. A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis. Br J Dermatol 2001; (145): 886-90
29. Leung D, Travers J, Giorno RD, et al. Evidence for a Streptococcal Superantigen-driven Process in Acute Guttate Psoriasis. J Clin Invest Inc 1995; 96 (11): 2106-2112
30. Cepicka W, Tielsch R. Focal infections and psoriasis vulgaris. Dermatol Wochenschr 1967; (153): 193-199
31. Ivanov OL, Mareeva EB. Unspeciphic syndroms. Rus J Dedrmatol Venerol 2010; (4): 4-10
32. Valdimarsson Н, Thorleifsdottir RH, Sigurdardottir SL, et al. Psoriasis — as an autoimmune disease caused by molecular mimicry. Trends in immunology 2009; 30 (10): 494-501
33. Grozdev I, Korman N, Tsankov N. Psoriasis as a systemic disease. Clinics in Dermatology 2013; doi: 10.1016/j. clindermatol. 2013.11.001
34. Tlish MM, Sycheva NL, Faustov LA. The clinical and morphological features of cuttate psoriasis. Clin Dermatol Venterol 2012; (5): 65-70
35. England R, Straachan D, Knight TL. Streptococcal tonsillitis and its association with psoriasis: a review. Clinical Otolaryngology & Allied Sciences 1997; (10): 532-535
36. Gudjonsson J, Thorarinsson A, Sigurgeirsson B, Kristinsson K, Valdimarsson H. Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study. British Journal of Dermatology 2003; (149): 530-534
37. Sigurdardottir SL, Thorleifsdottir RH, Valdimarsson H, Johnston A. The role palatine tonsils in the pathogenesis and treatment of psoriasis. Brit J of Dermatology. 2013; (168): 337-242
38. Kryukov Al, Tovmasjan AC, Drabkina IV, et al. The role microflore of etyology chronic tonsillitis. Vestn Otholaringol 2010; (3): 4-6
39. Majanski AN. Streptococci: microbyology and patology Woprosy dyagnostig of pediatry 2010; 2 (1): 9-20
40. Rosenberg EW, Patricia WN, Skinner RB. Microorganisms and psoriasis. J National Medical Ass 2009; 86 (4): 305-310
41. Gadjimirsaev GA. О nekotorix pologeniax problem chronic tonsillitis. Vestn Otholaringol 2010; (6): 34-35
42. Bukhova VP, Basanova ЕА, Borodiyk NA. Identificftion of determinant common for polysaccharidts of group A streptococcus, staphylococcus, and epidermal antigen of thymiv epitelium. Rus J Dedrmatol Venerol 1996; (4): 19-21
43. Korotky NG, Peslyak MY. Psoriasis as a consequence of incjrhjration of p-streptococci in the microbiocenosis of highly ptrmeable intestints (a patogenetic concept). Vestn Dermatol Venerol 2005; (5): 9-18
44. Lixoded VG, Uyshuk ND, Jakovlew MYu. Role endotoxine grammotrizatelnix bacteria v infeccionnoi i ne infeccionnoi patologie. Archiv Patology 1996; (2): 8-13
45. Duglas R, Main Е, Mac-Millin D, Nelson К. Systemic aspects of psoriasis: an integrative model based on intestinal etiology. Integrative Medicine 2000 (2): 105-119
46. Pogano Joa. Healing psoriasia: the natural alternative. M., 2001; 270 p Russian (Пегано Д. Лечение псориаза:естественный путь. М., 2001 ;270 с.
47. Mansood Q, ManzoorS, RukhsanaA. Treatment of acute guttate psoriasis with rifampicin. Indian J Dermatol Vcnereol Leprol 2000; (66): 296-8
48. Wilson JK, Sami BS, Al-Suwaidan N, Krowchuk D, Feldman SR. Treatment of Psoriasis in Children: Is There a Role for Antibiotic Therapy and Tonsillectomy? Pediatric Dermatology 2003; (20): 11-15
49. Jager MEA, Jong EM, van de Kerkhof GJ, et al. Efficacy and safety of childhood psoriasis: a systematic literature revive. J Am Acad Dermatol 2010; 62 (6): 1013-1030
50. Mesinkovska N.A., Tomecki K.J.. Novel systemic antibiotics in dermatology. Dermatologic Therapy 2012; (25): 1-5
51. Rosenberg EW, Noah PW, Skinner RB. Treatment of psoriasis with antimicrobial agents. In: Roenigk HH, Maibach HJ, eds. Psoriasis. New York: Marcel Dekker, 1965; p. 505-511
52. Rosenberg EW, Skinner RB, Noah PW. Anti-infectious therapy in psoriasis. In: Psoriasis (Roenigk HH, Maibach HI, eds), 3rd edn. New York: Marcel Dekker, 1998; (1): 373-379
53. Wolff K, Goldsmith LA, Katz SI. Fizpatricks Dermatology in General Medicine. New York, 2012
54. Color Atlas Synopsis of Pediatric Dermatology / Kay Shou-Mei Kane, Peter A. Lio, Alexander J. Stratigos, Richard Allen Johnson. Moskwa, 2011; 488 p.
55. Hoger PH. Kinderdermatologie. Differenzialdiagnostik und Therapie bei kindern und Jugendlichen. M., 2013; 634 s.
56. Cepicka W, Tielsch R. Focal infections and psoriasis vulgaris. Dematol Wochenschr 1967; (153): 193-199
57. Hone SW, Donnelly MJ, Powell F, Blayney AW. Clearance of recalcitrant psoriasis after tonsillectomy. Clin Otolaryngol Allied Sd 1996; (21): 546-547
58. Kataura A, Tsubota H. Clinical analyses of focus tonsil and related diseases in Japan. Acta Otolaryngol Suppl 1996; (523): 161-164
59. Ozawa A, Ohkido M, Haruki Y, et al. Treatmtnts of generalized pustular psoriasis: a multizenter study in Japan. J Dermatol 1999; (26): 141-14
60. Diluvio L, Campione E, Paterno EJ. et al. Childhood nail psoriasis: a useful treatmet with tasarotene 0,05%. Pediatr Dermatol 2007; (24): 332-3
61. Thorleifsdottir RH, Sigurdardottir SL, Sigurgeirsson B, et al. Improvement of psoriasis after tonsillectomy is associated writh a decrease in the frequency of circulating T cells that recognize streptococcal determinants and homologous skin determinants. J Immunol 2012; (188): 5160-5165
62. Malov VA, Рас CG. Aevolucion vzglada na role bacterialnix lipopolisaharidov v patology cheloveka. Vestn RAMN 1997; (8): 33-38
63. Hobejch MM. Heptral in therapy of psoriasis. Vestn Dermatol Venerol 2009; 3: 84-88. Russian (Хобейш M.M. Геп-трал в терапии псориаза. Вестн Дерматол Венерол 2009; (3): 84-88).